Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study

S Lohi
May 2009
Gut;May2009, Vol. 58 Issue 5, p643
Academic Journal
BACKGROUND AND AIMS: The association between diagnosed coeliac disease and malignancy has been established. The present study was conducted to determine whether previously unrecognised and thus untreated adults with screening-identified evidence of coeliac disease carry an increased risk of malignancies. METHODS: A Finnish population-based adult-representative cohort of 8000 individuals was drawn in 1978–1980. Stored sera of the participants with no history of coeliac disease or any malignancy were tested for immunoglobulin A (IgA) class tissue transglutaminase antibodies (Eu-tTG) in 2001. Positive sera were further analysed by another tissue transglutaminase antibody test (Celikey tTG) and for endomysial antibodies (EMAs). Malignant diseases were extracted from the nationwide database and antibody-positive cases were compared with negative cases during a follow-up of nearly 20 years. RESULTS: Altogether 565 of all the 6849 analysed serum samples drawn in 1978–80 were Eu-tTG positive. In further analyses, 202 (2.9%) of the participants were Celikey tTG positive and 73 (1.1%) were EMA positive. The overall risk of malignancy was not increased among antibody-positive cases in the follow-up of two decades; the age- and sex-adjusted relative risk was 0.91 (95% CI 0.60 to 1.37) for those who were Celikey tTG positive and 0.67 (95% CI 0.28 to 1.61) for those who were EMA positive. CONCLUSIONS: The prognosis of adults with unrecognised coeliac disease with positive coeliac disease antibody status is good as regards the overall risk of malignancies. Thus, current diagnostic practice is sufficient and there is no need for earlier diagnosis of coeliac disease by mass screening on the basis of the findings of this study.


Related Articles

  • An investigation of breast cancer risk factors in Cyprus: a case control study. Hadjisavvas, Andreas; Loizidou, Maria A.; Middleton, Nicos; Michael, Thalia; Papachristoforou, Rena; Kakouri, Eleni; Daniel, Maria; Papadopoulos, Panayiotis; Malas, Simon; Marcou, Yiola; Kyriacou, Kyriacos // BMC Cancer;2010, Vol. 10, p447 

    Background: Breast cancer is the most common form of malignancy affecting women worldwide. It is also the leading cancer in females in Cyprus, with approximately 400 new cases diagnosed annually. It is well recognized that genetic variation as well as environmental factors modulate breast cancer...

  • Screening for celiac disease, by endomysial antibodies, in patients with unexplained articular manifestations. Ghozzi, Mariam; Sakly, Wahiba; Mankaï, Amani; Bouajina, Elyes; Bahri, Fethi; Nouira, Rafiaa; Kechrid, Chedia; Ghedira, Ibtissem // Rheumatology International;May2014, Vol. 34 Issue 5, p637 

    Celiac disease (CD) is an autoimmune systemic disease characterized by not only gastrointestinal but also extraintestinal manifestations. The aim of our study was to do a serological screening for CD, by IgA endomysial antibodies (EmA), in patients with unexplained articular manifestations. Two...

  • Childhood coeliac disease diagnoses in Scotland 2009-2010: the SPSU project. White, Lois E.; Bannerman, Elaine; McGrogan, Paraic; Kastner-Cole, Dagmar; Carnegie, Elsie; Gillett, Peter M. // Archives of Disease in Childhood;Jan2013, Vol. 98 Issue 1, p52 

    Objectives: To establish the incidence of childhood coeliac disease (CD) in Scotland between 1 September 2009 and 31 August 2010, to determine clinical features at presentation and reasons for diagnosis, and to identify any differences in incidence and practice between regions. Design:...

  • Plasma Enterolignan Concentrations and Colorectal Cancer Risk in a Nested Case-Control Study. Anneleen Kuijsten; Peter C. H. Hollman; Hendriek C. Boshuizen; Michel N. C. P. Buijsman; Pieter van t Veer; Frans J. Kok; Ilja C. W. Arts; H. Bas Bueno-de-Mesquita // American Journal of Epidemiology;Mar2008, Vol. 167 Issue 6, p734 

    Enterolignans are biphenolic compounds that possess several biologic activities whereby they may influence carcinogenesis. The authors investigated the association between plasma enterolactone and enterodiol and colorectal cancer risk in a Dutch prospective study. Among more than 35,000...

  • NICE clinical guideline 86. Coeliac disease: recognition and assessment of coeliac disease. Jones, Hayley J.; Warner, Justin T. // Archives of Disease in Childhood -- Education & Practice Edition;Apr2010, Vol. 95 Issue 4, p17 

    The article presents information on the guideline "Recognition and assessment of coeliac disease" from the British National Institute for Clinical Excellence (NICE) which involves screening of children and young people who have been diagnosed with type 1 diabetes.

  • Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk. Sovio, U; Li, J; Aitken, Z; Humphreys, K; Czene, K; Moss, S; Hall, P; McCormack, V; dos-Santos-Silva, I // British Journal of Cancer;4/1/2014, Vol. 110 Issue 7, p1908 

    Background:Mammographic density is a strong risk factor for breast cancer but the lack of valid fully automated methods for quantifying it has precluded its use in clinical and screening settings. We compared the performance of a recently developed automated approach, based on the public domain...

  • Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. McMillan, Stanley A.; Haughton, David J.; Biggart, J. Dennis; Edgar, J. David; Porter, Kenneth G.; McNeill, Thomas A. // BMJ: British Medical Journal (International Edition);11/9/91, Vol. 303 Issue 6811, p1163 

    Examines the predictive value for celiac diseases of antibodies in patients with jejunal biopsy. Detection of gliadin IgA in patients; Symptoms of the disease; Presence of endomysial antibodies found using indirect immunofluorescence.

  • Antibody tests to simplify coeliac disease diagnosis.  // Pulse;5/19/2010, Vol. 70 Issue 17, p9 

    The article focuses on the study conducted by primary care researchers at the University of Keele in Staffordshire, England concerning the effectiveness of gastrointestinal and serum antibody tests for coeliac disease diagnosis.

  • Gliadin antibody levels: a serological test for coeliac disease. O'Farrelly, Cliona; Kelly, J.; Hekkens, W.; Bradley, B.; Thompson, A.; Feighery, C.; Weir, D.G. // British Medical Journal (Clinical Research Edition);6/25/1983, Vol. 286 Issue 6383, p2007 

    Assesses the diagnostic value in coeliac disease of circulating antibodies to casein, crude and alpha gliadin. Adaptation of the enzyme linked immunosorbent assay system; Validity of the serological test; Increase in the levels of alpha gliadin antibody.


Read the Article


Sign out of this library

Other Topics